In the wake of the germline editing controversy, when Chinese scientist He Jianku illegally edited the embryos of human twins ...
Researchers at the Peter Doherty Institute for Infection and Immunity (Doherty Institute) have developed a world-first ...
CRISPR obtained approval for Casgevy back in 2023, but the rollout has been slow. In 2025, the company incurred a loss of more than $580 million. Its cash position, however, remains strong.
Researchers at Sanofi report that cas-CLOVER (deactivated Cas9 fused to the C-terminus of Clostridium Clo051) gene editing has the potential to notably enhance recombinant protein production in ...
Over thousands of years of domestication, humans have moulded fruit to their liking. Today’s peaches are 16 times the size of their ancient ancestors. The 1,200 varieties of watermelon bear little ...
CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the top gene therapy stocks to buy according to hedge funds. On February 17, Morgan Stanley lifted the price target on CRISPR Therapeutics AG ...
A caffeine-triggered switch that turns CRISPR gene editing on and off inside cells could one day improve cancer therapy.
When a cocaine addict relapses, it isn’t a matter of personal failure — it’s the biological result of their brain’s rewiring, ...
Japan's synthetic biology market is poised for growth due to increased demand for bio-products and advances in CRISPR and DNA synthesis. Key opportunities lie in healthcare, agriculture, and ...
When a cocaine addict relapses, it isn't a matter of personal failure — it's the biological result of their brain's rewiring, new research ...
As Pioneer marks 100 years, leaders say gene editing and advanced data tools are poised to drive the next leap in corn yield, building on a century of gains from hybrids, biotech and management ...